Brief: Cormedix Inc. Announces New Commercial Agreement
Sept 9 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC. ANNOUNCES NEW COMMERCIAL AGREEMENT
* CORMEDIX INC - ENTERS MULTI-YEAR SUPPLY CONTRACT FOR
DEFENCATH
* CORMEDIX INC - EXPECTS TO INITIALLY TARGET UTILIZATION OF
DEFENCATH IN UP TO 4,000 PATIENTS NATIONALLY
* CORMEDIX INC - DEFENCATH SHIPMENTS UNDER AGREEMENT TO
BEGIN IN
Q4
Source text for Eikon: ID:nGNX3SYTRc
Further company coverage: CRMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary